Using patient's own cells

The safety of the proprietary adult stem cell technology using a patient's own (autologous) Mesenchymal Precursor Cells has been shown in Pilot Clinical Trials conducted in Australia . During the trials at The Royal Melbourne Hospital and the John Hunter Hospital , autologous MPC were isolated and grown up in culture using the proprietary platform technology.

For more information, please see:

http://mesoblast.com/mediareleases/news_mediareleases89.pdf  
and
http://mesoblast.com/mediareleases/news_mediareleases70.pdf

Product Development

• GMP Process Development
• Proof of Principle Model
• Clinical Trials
  • Autologous
  • Allogeneic